Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04126824 · ClinicalTrials.gov registry record · Early Phase 1
Effect of Addition of Steroids on Duration of Analgesia
A Early Phase 1 study of Uterine Fibroids and Adenomyosis, sponsored by University of California, Los Angeles.
- Active
- Registry status
- Early Phase 1
- Development phase
- 28
- Enrollment target
- 2
- Study locations
NCT04126824: Active Early Phase 1 study of Uterine Fibroids and Adenomyosis, sponsored by University of California, Los Angeles.
NCT04126824 is a Early Phase 1 study of Uterine Fibroids and Adenomyosis that is active but no longer recruiting, run by University of California, Los Angeles. The registered enrollment target is 28 participants, below the 241-participant average among 10 other Uterine Fibroids trials with a reported enrollment target (88% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04126824, a Early Phase 1 study of Uterine Fibroids and Adenomyosis, is active but no longer recruiting, sponsored by University of California, Los Angeles.
- ACTIVE NOT RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 28 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of the study is to investigate the differences in post-procedural pain scores and narcotic use among patients who receive a Superior Hypogastric Nerve Block (SHNB) with and without corticosteroid performed as part of the Uterine Artery Embolization (UAE) procedure.
Primary Outcome
The pain intensity is assessed using a visual analogue scale (VAS), which is a horizontal line 100 mm in length. Subjects mark the VAS with a single vertical line to indicate their current pain level, with 0 mm representing "No Pain" and 100 mm representing "Worst Possible Pain".
Conditions Studied
Interventions
- DRUG Bupivacaine
- DRUG Triamcinolone
- OTHER Iohexol contrast
Study Locations (2)
California
- University of California, Los Angeles - Westwood, Los Angeles
North Carolina
- University of North Carolina - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2022-01-06 |
| Est. Completion | 2027-08-02 |
| Phase | Early Phase 1 |
What the registry record for NCT04126824 still lists
NCT04126824 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 241-participant average among 10 other Uterine Fibroids trials with a reported enrollment target (88% lower).
The record links to 2 conditions, with Uterine Fibroids appearing as the primary indexed condition, and to 3 interventions - of which Bupivacaine is the first listed.
NCT04126824 reports a single indexed study location in California, North Carolina.
Frequently Asked Questions
What is clinical trial NCT04126824 about?
NCT04126824 is a clinical study titled "Effect of Addition of Steroids on Duration of Analgesia". The purpose of the study is to investigate the differences in post-procedural pain scores and narcotic use among patients who receive a Superior Hypogastric Nerve Block (SHNB) with and without corticosteroid performed as part of the Uterine Artery Embolization (UAE) procedure.
What is the current status of trial NCT04126824?
This trial is currently active not recruiting. It is a Early Phase 1 study. The enrollment target is 28 participants. The study started on 2022-01-06. Estimated completion is 2027-08-02.
What conditions does trial NCT04126824 study?
This clinical trial studies the following conditions: Uterine Fibroids, Adenomyosis.
What interventions are being tested in trial NCT04126824?
The interventions under investigation include: Bupivacaine (DRUG), Triamcinolone (DRUG), Iohexol contrast (OTHER).
Who is sponsoring clinical trial NCT04126824?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04126824 being conducted?
This trial has 2 study locations across California, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Uterine Fibroids
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04126824's enrollment target sits among peer trials
28 9th of 10 higher than 2 of 10 other Uterine Fibroids trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Uterine Fibroids trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
An Open-Label Study to Evaluate the Effect of Elix Cycle Balance & Elix Daily Harmony on Fibroid-related Symptoms
RECRUITING · NA
-
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
RECRUITING · Phase 3
-
Uterine Leiomyoma Treatment With Radiofrequency Ablation (ULTRA) Registry
ACTIVE NOT RECRUITING
-
Uterine Leiomyoma Treatment With Radiofrequency Ablation
COMPLETED · NA
-
Extension Study of Proellex in Women Who Have Previously Completed Study ZPU 003
COMPLETED · Phase 2
-
Optimal Order of Concurrent Office Hysteroscopy and Endometrial Biopsy
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI